04:55 PM EST, 03/05/2024 (MT Newswires) -- Marinus Pharmaceuticals ( MRNS ) reported Q4 net loss late Tuesday of $0.74 per diluted share, compared with a loss of $0.76 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.62.

Total revenue for the quarter ended Dec. 31 was $7.19 million, up from $7.16 million a year earlier. Analysts surveyed by Capital IQ expected $8.1 million.

The company shares were down about 24% in after-hours trading.

Price: 7.04, Change: -2.2, Percent Change: -23.81